Colgate-Palmolive Company (LON:0P59)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 51.42B |
| Revenue (ttm) | 14.60B |
| Net Income (ttm) | 2.12B |
| Shares Out | n/a |
| EPS (ttm) | 2.60 |
| PE Ratio | 24.23 |
| Forward PE | 22.71 |
| Dividend | 1.57 (1.82%) |
| Ex-Dividend Date | Jul 18, 2025 |
| Volume | 3,636 |
| Average Volume | 17,153 |
| Open | 85.50 |
| Previous Close | 84.48 |
| Day's Range | 85.11 - 86.94 |
| 52-Week Range | 81.12 - 109.22 |
| Beta | 0.39 |
| RSI | 49.29 |
| Earnings Date | Aug 1, 2025 |
About Colgate-Palmolive Company
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells i... [Read more]
Financial Performance
In 2024, Colgate-Palmolive Company's revenue was $20.10 billion, an increase of 3.31% compared to the previous year's $19.46 billion. Earnings were $2.89 billion, an increase of 25.61%.
Financial numbers in USD Financial StatementsNews
Top 3 Risk Off Stocks That May Rocket Higher This Quarter
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Recent Filing Shows That Sen. Shelley M Capito Bought Over $17K Worth of American Express Stock
A August filing shows that Senator Shelley M Capito reported a purchase in American Express (NYSE: AXP), valued between $17,003 and $80,000. The transaction date is listed as July 1, 2025, with the r...
These Analysts Lower Their Forecasts On Colgate-Palmolive After Q2 Results
Colgate-Palmolive Company (NYSE: CL) posted better-than-expected second-quarter earnings on Friday . Colgate-Palmolive reported second-quarter adjusted earnings per share of 92 cents, beating the ana...
These Analysts Lower Their Forecasts On Colgate-Palmolive After Q2 Results
Colgate-Palmolive Company CL posted better-than-expected second-quarter earnings on Friday.
Colgate Plans More Price Increases to Offset Slower Sales, Higher Costs
Colgate-Palmolive Company (CL) Q2 2025 Earnings Call Transcript
Colgate-Palmolive Company 2025 Q2 - Results - Earnings Call Presentation
Colgate-Palmolive beats quarterly estimates on steady demand for essentials
Colgate-Palmolive beat first-quarter sales and profit estimates on Friday, as resilient demand for its essentials such as oral and personal care products overcame rising prices and tariff uncertaintie...
Colgate-Palmolive's Outlook Remains Cautious As Restructuring Plans Take Shape
Colgate-Palmolive Company (NYSE: CL) is brushing up its future with a bold 2030 plan, even as it takes on up to $300M in restructuring charges . The move comes as the oral care giant topped second-qu...
Colgate-Palmolive beats quarterly estimates on steady demand for essentials
Colgate-Palmolive beat first-quarter sales and profit estimates on Friday, as resilient demand for its essentials such as oral and personal care products overcame rising prices and tariff uncertaintie...
CL Earnings: All you need to know about Colgate-Palmolive’s Q2 2025 earnings results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2025 earnings results today. Net sales increased 1% year-over-year to $5.1 billion. Organic sales growth was 1.8%. Net income attributa...
Colgate-Palmolive Non-GAAP EPS of $0.92 beats by $0.03, revenue of $5.11B beats by $80M
Colgate-Palmolive Company Announces 2nd Quarter 2025 Results
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL): Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales GAAP EPS in...
Earnings Scheduled For August 1, 2025
Companies Reporting Before The Bell • Brookfield Business (NYSE: BBUC) is expected to report earnings for its second quarter. • TELUS (NYSE: TU) is likely to report quarterly earnings at $0.17 per s...
Price Over Earnings Overview: Colgate-Palmolive
In the current session, Colgate-Palmolive Inc. (NYSE: CL) is trading at $85.35, after a 0.52% drop. Over the past month, the stock decreased by 9.06% , and in the past year, by 17.94% . With performa...
Colgate-Palmolive Q2 2025 Earnings Preview
A Look Ahead: Colgate-Palmolive's Earnings Forecast
Colgate-Palmolive (NYSE: CL) is preparing to release its quarterly earnings on Friday, 2025-08-01. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expe...
JP Morgan Lowers Price Target for Colgate-Palmolive (CL) | CL Stock News
JP Morgan Lowers Price Target for Colgate-Palmolive (CL) | CL Stock News
Colgate Women's Games Teams Up with World-Class Athletes Sha'Carri Richardson, Ajeé Wilson and Natasha Hastings for Milestone 50th Season
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company announced today that Colgate Women's Games, the nation's longest-running indoor Track & Field series for girls and women, will return this December...
Top brokerages on Colgate share: Citi, HSBC, GS bearish post Q1 miss; Nuvama expects H2 recovery
Colgate-Palmolive India’s Q1FY26 results have triggered a range of reactions from brokerages, with target prices spanning from as low as ₹2,175 to as high as ₹3,135. While most firms have cited weak d...
Citi maintains sell on Colgate, trims target to Rs 2,175 citing competition and muted demand
Citi has reiterated its Sell rating on Colgate-Palmolive India and reduced the target price from ₹2,300 to ₹2,175 per share, citing continued pressure from weak urban demand and heightened competitive...
Colgate share: Goldman Sachs maintains sell, sees downside with ₹2,300 target after weak Q1 and earnings cut
Goldman Sachs has reiterated its Sell rating on Colgate-Palmolive India and set a target price of ₹2,300 per share, implying a downside from the current market price of ₹2,375.90. The brokerage highli...
5 Ideal "Safer" Dividend Buys From Bloomberg's July Watch List
Bloomberg's 50 Companies to Watch leverages catalysts like new leadership, AI, and policy shifts to identify high-potential stocks for 2025. Yield-based 'dogcatcher' analysis spotlights 15 dividend pa...
Best Dividend Kings: July 2025
14 Dividend Kings continue to outperform the S&P 500 in 2025. Dividend growth remains healthy, with one recent increase and a collective 2025 growth rate of 5.23%. Seventeen Dividend Kings currently a...
India's Colgate-Palmolive quarterly profit dips on rising competition, tepid urban demand
Colgate Palmolive India reported a decline in first-quarter profit on Tuesday, as feeble urban demand and intensified competition in its core oral care business weighed on sales.